Sialyltransferase ST3GAL1 promotes cell migration, invasion, and TGF-β1-induced EMT and confers paclitaxel resistance in ovarian cancer. [electronic resource]
Producer: 20191210Description: 1102 p. digitalISSN:- 2041-4889
- Animals
- Antigens, CD -- genetics
- Antineoplastic Agents, Phytogenic -- pharmacology
- Cadherins -- genetics
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Drug Resistance, Neoplasm -- genetics
- Epithelial-Mesenchymal Transition -- drug effects
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Invasiveness
- Ovarian Neoplasms -- drug therapy
- Paclitaxel -- pharmacology
- RNA, Small Interfering -- genetics
- Sialyltransferases -- antagonists & inhibitors
- Signal Transduction
- Transforming Growth Factor beta1 -- genetics
- Tumor Burden -- drug effects
- Xenograft Model Antitumor Assays
- beta-Galactoside alpha-2,3-Sialyltransferase
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.